Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? DEFICIT (Details Narrative 3)

v3.24.0.1
STOCKHOLDERS’ DEFICIT (Details Narrative 3) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
May 31, 2019
Dec. 31, 2023
Jun. 30, 2023
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Restricted stock units, value    
Restricted Stock Units (RSUs) [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Restricted stock units, shares 0.117    
Restricted stock units, value $ 4,250,000    
Fair value granted, shares $ 497,240    
Unrecognized restricted stock units expense   $ 248,620 $ 248,620
Restricted stock units not yet vested, shares   $ 248,620  
Unvested Restricted Stock Units [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Unvested restricted stock units   0.06 0.06
Chief Executive Officer [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Restricted stock units, shares 0.078    
Chief Scientific Officer [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Restricted stock units, shares 0.039